Lanifibranor Uses, Dosage, Side Effects and more
Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337).
| Attribute | Details |
|---|---|
| Trade Name | Lanifibranor |
| Generic | Lanifibranor |
| Lanifibranor Other Names | Lanifibranor |
| Type | |
| Formula | C19H15ClN2O4S2 |
| Weight | Average: 434.91 Monoisotopic: 434.016177 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
